SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-370225
Filing Date
2015-11-06
Accepted
2015-11-06 16:36:34
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d53155d10q.htm 10-Q 602851
2 EX-31.1 d53155dex311.htm EX-31.1 8454
3 EX-31.2 d53155dex312.htm EX-31.2 8461
4 EX-32.1 d53155dex321.htm EX-32.1 2804
5 EX-32.2 d53155dex322.htm EX-32.2 2818
  Complete submission text file 0001193125-15-370225.txt   3362677

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20150930.xml EX-101.INS 548641
7 XBRL TAXONOMY EXTENSION SCHEMA agio-20150930.xsd EX-101.SCH 39343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20150930_cal.xml EX-101.CAL 48101
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20150930_def.xml EX-101.DEF 132411
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20150930_lab.xml EX-101.LAB 346973
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20150930_pre.xml EX-101.PRE 239910
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 151212843
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences